Home » Topics » Regulatory » Patents

Patents
RSS

New anticancer agents imparted in recent patents

Dec. 1, 2008

Recent Novartis patent reports new S1P1 receptor ligands intended for transplant rejection

Dec. 1, 2008

New agents for treating neurological disorders disclosed in recent patent literature

Dec. 1, 2008

Recent AstraZeneca and Abbott patents report novel analgesic agents

Nov. 28, 2008

New antiobesity agents described in recent Schering-Plough patent

Nov. 28, 2008

Recent patents describe novel antidiabetic agents

Nov. 28, 2008

Recent GSK patents disclose novel agents for tuberculosis

Nov. 27, 2008

New immunomodulatory agents disclosed in recent Novartis patent

Nov. 27, 2008

Novel PGE2 receptor modulators emerge from Astellas R&D

Nov. 27, 2008

Novel therapeutic agents for cancer cachexia and muscle wasting imparted in recent Santhera patent

Nov. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...